Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristopher K Frese

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Nature Reviews. Cancer|August 10, 2007
Maximizing mouse cancer modelsKristopher K Frese, David A Tuveson
Cancer Cell|February 12, 2021
Small cell lung cancer enters the era of precision medicineKristopher K Frese, Kathryn L Simpson, Caroline Dive
Translational Lung Cancer Research|September 15, 2017
Circulating tumor cells and CDX models as a tool for preclinical drug developmentAlice Lallo, Maximilian W Schenk, Kristopher K Frese, et al.
The Lancet. Oncology|September 8, 2018
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?Fiona Blackhall, Kristopher K Frese, Kathryn Simpson, et al.
Cancer Discovery|November 2, 2011
C-Raf is required for the initiation of lung cancer by K-Ras(G12D)Florian A Karreth, Kristopher K Frese, Gina M DeNicola, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Journal of Virology|February 23, 2007
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesiclesSang-Hyuk Chung, Kristopher K Frese, Robert S Weiss, et al.
Journal of Cell Science|September 6, 2005
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cellsIsabel J Latorre, Michael H Roh, Kristopher K Frese, et al.
Cancer Discovery|May 16, 2012
nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancerKristopher K Frese, Albrecht Neesse, Natalie Cook, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Targeting DNA damage in SCLCVictoria Foy, Maximilian W Schenk, Katie Baker, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Nature Reviews. Cancer|August 10, 2007
Maximizing mouse cancer modelsKristopher K Frese, David A Tuveson
Cancer Cell|February 12, 2021
Small cell lung cancer enters the era of precision medicineKristopher K Frese, Kathryn L Simpson, Caroline Dive
Translational Lung Cancer Research|September 15, 2017
Circulating tumor cells and CDX models as a tool for preclinical drug developmentAlice Lallo, Maximilian W Schenk, Kristopher K Frese, et al.
The Lancet. Oncology|September 8, 2018
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?Fiona Blackhall, Kristopher K Frese, Kathryn Simpson, et al.
Cancer Discovery|November 2, 2011
C-Raf is required for the initiation of lung cancer by K-Ras(G12D)Florian A Karreth, Kristopher K Frese, Gina M DeNicola, et al.
Open Biology|January 13, 2021
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectoriesRobert E Hynds, Kristopher K Frese, David R Pearce, et al.
Journal of Virology|February 23, 2007
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesiclesSang-Hyuk Chung, Kristopher K Frese, Robert S Weiss, et al.
Journal of Cell Science|September 6, 2005
Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cellsIsabel J Latorre, Michael H Roh, Kristopher K Frese, et al.
Cancer Discovery|May 16, 2012
nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancerKristopher K Frese, Albrecht Neesse, Natalie Cook, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Targeting DNA damage in SCLCVictoria Foy, Maximilian W Schenk, Katie Baker, et al.
Pageof 4